- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 8.24M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 5.35M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.26M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.97M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $5.02M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $5.21M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $22.83M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $14.48M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $19.2M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $21M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.53M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.53M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.53M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.53M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $25.24M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $16.88M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $25.36M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $17.01M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.54 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.35 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.54 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.35 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.2M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.12M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.76M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.06M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.67M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.86M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.85M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.09M |